Association between cine CMR-based radiomics signature and microvascular obstruction in patients with ST-segment

Yongjia Peng1, Kongyang Wu2, Yi Xiang J Wang3

  • 1The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.

Insights

This study shows that cine cardiac magnetic resonance (CMR)-based radiomics can predict microvascular obstruction (MVO) in ST-segment elevation myocardial infarction (STEMI) patients. This contrast-free imaging biomarker offers a new way to assess MVO after percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiology
  • Medical Imaging
  • Radiology

Background:

  • Patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) may receive contrast agents.
  • Iodine and gadolinium contrast agents can cause adverse events.
  • Assessing microvascular obstruction (MVO) is crucial in STEMI management.

Purpose of the Study:

  • To investigate the association between cine cardiac magnetic resonance (CMR)-based radiomics signatures and MVO in STEMI patients.
  • To explore the potential of a contrast-free radiomics signature as an imaging biomarker for MVO.

Main Methods:

  • Retrospective analysis of 116 STEMI patients who underwent CMR within 6 days post-PCI.
  • Radiomic features extracted from cine CMR images; feature selection using the least absolute shrinkage and selectionator operator (LASSO) algorithm.
  • Binary logistic regression used to assess the association between radiomics signatures and MVO, adjusted for clinical factors.

Main Results:

  • A radiomics signature comprising five features was constructed.
  • Radiomics score, high-sensitivity C-reactive protein (hs-CRP), and creatine phosphokinase (CPK) were independent risk factors for MVO.
  • The radiomics score showed an area under the receiver operating characteristic curve (AUC) of 0.75 for predicting MVO.

Conclusions:

  • Cine CMR-based radiomics signature is an independent predictor of MVO in STEMI patients.
  • This contrast-free radiomics signature shows potential as an imaging biomarker for MVO.
  • Further validation may establish its role in clinical practice for MVO assessment.
Abstract